TITLE

Database analysis of children and adolescents with Bipolar Disorder consuming a micronutrient formula

AUTHOR(S)
Rucklidge, Julia J.; Gately, Dermot; Kaplan, Bonnie J.
PUB. DATE
January 2010
SOURCE
BMC Psychiatry;2010, Vol. 10, p74
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Eleven previous reports have shown potential benefit of a 36-ingredient micronutrient formula known as EMPowerplus) for the treatment of psychiatric symptoms. The current study asked whether children (7-18 years) with pediatric bipolar disorder (PBD) benefited from this same micronutrient formula; the impact of Attention-Deficit/Hyperactivity Disorder (ADHD) on their response was also evaluated. Methods: Data were available from an existing database for 120 children whose parents reported a diagnosis of PBD; 79% were taking psychiatric medications that are used to treat mood disorders; 24% were also reported as ADHD. Using Last Observation Carried Forward (LOCF), data were analyzed from 3 to 6 months of micronutrient use. Results: At LOCF, mean symptom severity of bipolar symptoms was 46% lower than baseline (effect size (ES) = 0.78) (p < 0.001). In terms of responder status, 46% experienced >50% improvement at LOCF, with 38% still taking psychiatric medication (52% drop from baseline) but at much lower levels (74% reduction in number of medications being used from baseline). The results were similar for those with both ADHD and PBD: a 43% decline in PBD symptoms (ES = 0.72) and 40% in ADHD symptoms (ES = 0.62). An alternative sample of children with just ADHD symptoms (n = 41) showed a 47% reduction in symptoms from baseline to LOCF (ES = 1.04). The duration of reductions in symptom severity suggests that benefits were not attributable to placebo/expectancy effects. Similar findings were found for younger and older children and for both sexes. Conclusions: The data are limited by the open label nature of the study, the lack of a control group, and the inherent self-selection bias. While these data cannot establish efficacy, the results are consistent with a growing body of research suggesting that micronutrients appear to have therapeutic benefit for children with PBD with or without ADHD in the absence of significant side effects and may allow for a reduction in psychiatric medications while improving symptoms. The consistent reporting of positive changes across multiple sites and countries are substantial enough to warrant a call for randomized clinical trials using micronutrients.
ACCESSION #
55091706

 

Related Articles

  • BÄ°POLAR HASTALARDA DEPRESÄ°F DÖNEM ÖYKÃœSÃœ VARLIÄžINA GÖRE KLÄ°NÄ°K VE SOSYODEMOGRAFÄ°K ÖZELLÄ°KLERÄ°N KARÅžILAÅžTIRILMASI. AKARSU, Süleyman; ERDEM, Murat; ÜNLÜ, Abdulvahap Gazi; ALPER, Mustafa; KARAMAN, Dursun; AK, Mehmet // Anatolian Journal of Clinical Investigation;2012, Vol. 6 Issue 2, p104 

    The aim of this study was to compare the sociodemographic and clinic characteristics of patients with bipolar disorder type I with and without history of depressive episode. In this study the data of 108 bipolar type I patients who were admitted to psychiatry clinic of a university hospital due...

  • new drug to fight bipolar II.  // Good Medicine (Australian Consolidated Press);Jun2004, p16 

    Reports on the plan of the Black Dog Institute to conduct a trial to determine if antidepressant drug escitalopram is an effective treatment for bipolar disorder II. Information for those who want to take part in the trial.

  • Influence of sub-syndromal symptoms after remission from manic or mixed episodes. Tohen, Mauricio; Bowden, Charles L.; Calabrese, Joseph R.; Lin, Daniel; Forrester, Tammy D.; Sachs, Gary S.; Koukopoulos, Athanasios; Yatham, Lakshmi; Grunze, Heinz // British Journal of Psychiatry;Dec2006, Vol. 189, p515 

    Background Sub-syndromal symptoms in bipolar disorder impair functioning and diminish quality of life. Aims To examine factors associated with time spent with sub-syndromal symptoms and to characterise how these symptoms influence outcomes. Method In a double-blind randomised maintenance trial,...

  • Exposure to obstetric complications and subsequent development of bipolar disorder: Systematic review.  // British Journal of Psychiatry;Jul2006, Vol. 189, p3 

    Background Research has suggested an association between obstetric complications and bipolar disorder. However, no quantitative evaluation has been made of the pooled data from existing studies. Aims To systematically review studies comparing exposure to obstetric complications in cases of...

  • Prospective 12-month course of bipolar disorder in out-patients with and without comorbid anxiety disorders.  // British Journal of Psychiatry;Jul2006, Vol. 189, p20 

    Background The impact of anxiety disorders has not been well delineated in prospective studies of bipolar disorder. Aims To examine the association between anxiety and course of bipolar disorder, as defined by mood episodes, quality of life and role functioning. Method A thousand out-patients...

  • GIRL, INTERRUPTED: ONE READER TELLS... Cassimatis, Georgia // Cleo;May2004, Issue 379, p164 

    Presents information on bipolar disorder, a mood disorder. Types of bipolar disorders; Persons affected by the disorder; Characterization of the disorder.

  • Bipolar disorder. Geddes John // Evidence Based Mental Health;Nov2003, Vol. 6 Issue 4, p101 

    Summarizes information about bipolar disorder. Definition; Incidence/prevalence; Etiology and risk factors; Prognosis; Effects of treatments in mania, including lithium, olanzapine, valproate, carbamazepine and risperidone; Effects of treatments with lamotrigine, antidepressants, lithium and...

  • q1Bipolar spectrum features in drug resistant unipolar depression patients: TRES-DEP pilot study. Dudek, Dominika; Siwek, Marcin; Borowiecka-Kluza, Joanna; Pawłowski, Tomasz; Kiejna, Andrzej; Łojko, Dorota; Rybakowski, Janusz K. // Archives of Psychiatry & Psychotherapy;Jun2009, Vol. 11 Issue 2, p65 

    Aim. The aim this pilot study of the all-Polish multicenter TRES-DEP (Treatment Resistant Depression) project was the detection and analysis of bipolar spectrum features in drug-resistant (DR) patients with unipolar depression in comparison with patients who responded to standard antidepressant...

  • Son la depresión y el trastorno bipolar la misma enfermedad? Hirschfeld, Robert M.A. // American Journal of Psychiatry - Edición Española;Oct2005, Vol. 8 Issue 9, p513 

    No abstract available.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics